Digital Media briefs: August 2013

Share this article:
Digital Media briefs: August 2013
Digital Media briefs: August 2013

Ray Manna has moved over from TogoRun/Fleishman Hillard to DJM Digital Solutions where he will be SVP, North America. Manna's previous gig was SVP and digital/social media and marketing director, a role in which he developed offerings for clients including IMS Health, Janssen, BMS and Bayer Cardio.

Mobile health users are on the hunt for information and possibly for new treatments as well, according to a Digitas Health survey that was reported on by PMLive. Digitas also found that women made up the majority of mHealth users and that 90% would take up their doctor on a mobile app prescription.

User trends indicate that rich mobile experiences and the pharma industry need to be on good terms. A report by Strategy Analytics shows that wireless traffic is projected to climb from 5 exabytes of data a year to over 21 by 2017.

MSN's Bing Health and Fitness app (pictured above) is flexing its muscles in the consumer space. The new app lets users track how much they eat, in addition to keeping tabs on the nutritional value of their meals and how much exercise is needed to burn off caloric overages.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?